Oncology Case Studies
A breast cancer survivor experiencing sex-related headaches after treatment.
54 year old man presents to the emergency department with progressive right-sided facial swelling.
An active 71 year old male referred to our second opinion clinic in June 2011 due to persistently elevated PSA levels.
A man recently diagnosed with stage IV pancreatic adenocarcinoma is 10 days from a stent placement for hyperbilirubinemia. He is an engineer and intends to work from home during his treatment.
A 55-year-old woman with stage 4 estrogen receptor/progesterone receptor–positive breast cancer is admitted to the hospital for worsening shortness of breath.
A female patient presents with oral discomfort, weight loss, and a 30-pack year cigarette smoking history.
A 53-year-old female complains of mouth pain after 4 weeks of therapy with exemestane plus everolimus.
A female diagnosed with Ph+ acute lymphoblastic leukemia presents with anemia, neutropenia, and heartburn.
A female with a large cystic mass, upper abdominal pain, and nausea presents. What is her diagnosis?
Can you guess how to manage this patient's grade 3 acneiform rash?
A 64-year-old woman complains of chest pain 5 days after hospital admission for administration of FOLFOX chemotherapy to treat colorectal cancer. What's the diagnosis?
A man with multiple myeloma develops a low grade fever and mild diarrhea 10 days after receiving a successful autologous hematopoietic stem cell transplant.
64-year-old gentleman presents with a 6-month history of rash that started on his upper extremities and now includes his lower extremities.
A 48-year-old female has experienced ongoing fatigue since the beginning of cytotoxic chemotherapy, 6 months after initiating trastuzumab.
A 38-year-old female presents with a fever and abdominal pain about 2 weeks after her most recent chemotherapy treatment.
A 72-year-old male presents with a large right renal mass and a mass within the liver suspicious for a metastatic focus.
A middle-aged male patient presents with swollen joints, a history of infections, and pancytopenia. What's his diagnosis?
A 63-year-old male presented with shortness of breath, persistent cough, and a chest x-ray suspicious for malignancy.
After being treated with radioiodine therapy for papillary thyroid cancer, this patient presented with pancytopenia.
A middle-aged man with a 35 pack-year smoking history and extensive history of sun exposure presents with a lesion in the nose.
Dr. E. David Crawford, Head Urologic Oncology at the University of Colorado, presents his case study on renal cell carcinoma (RCC).
Although there are new therapies for M1CRPC patients and others pending, ideal sequencing regimen is still not certain.
Although prevalence of cytogenetic abnormality in tumor biopsy is low, finding one or more abnormalities can expand the patient's treatment options.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Era of Precision Oncology for Prostate Cancer 'Is Upon Us'
- Veliparib and Carboplatin May Be Effective Against Triple-negative Breast Cancer
- Metastatic Prostate Cancer Cases On the Rise in the U.S.
- Some Patients With Locally Advanced Rectal Cancer May Avoid Surgery
- Some Patients With Endocrine-responsive Early-stage Breast Cancer May Avoid Chemotherapy
- Multiple Myeloma May Be Linked to Pesticide Exposure
- Immune Therapies May Offer Promise for Hormone-receptor-positive Breast Cancer
- First-line Nivolumab Plus Platinum-based Doublet Active in Advanced NSCLC
- Senescent Effects on Cancer Cells Are Context-dependent
- Breast-conserving Surgery and Radiotherapy May Provide Better Overall Survival Than Mastectomy
- Life Expectancy of Patients With CML Greatly Improved, but at What Cost?
- Costs of Malignant Blood Disorders in European Countries Reached €23 Billion in 2012
- Achieving Negative Margin Essential for Optimizing Local Control, Survival in Sarcoma
- Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?
- FDA Declines to Approve Pegfilgrastim Biosimilar